Psilocybin Therapy for Depression - Clinical Insights

After the release of the first comparison of psilocybin with an SSRI antidepressant, Michelle Baker Jones & Leonie Schneider explain what psilocybin therapy for depression involves. Leonie was a patient of Michelle in psilodep 1, and together they provide insight into psilocybin therapy from the perspective of both therapist and patient. Michelle Baker Jones is  …


Psilocybin Treatment for Depression - Clinical Insights

Psilocybin for depression is one of the most promising applications of psychedelic therapy. In particular, psilocybin therapy is being studied as an alternative to antidepressants in the treatment of treatment-resistant depression. In this Drug Science webinar, Dr Mourad Wahba explains the science behind psilocybin for depression, which is currently in clinical trials at a number  …


Clinical Insights - MDMA for Alcohol Use Disorder

Dr Ben Sessa – MDMA for Alcohol Use Disorder Dr Ben Sessa presents the first data from the open-label safety and tolerability proof of concept study exploring the potential role for 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in treating patients with alcohol use disorder. At this stage, seven participants have completed the full 8-week MDMA-assisted psychotherapy treatment course,  …


Clinical Insights - Psilocybin for Anorexia Nervosa

Dr Meg Spriggs – Psilocybin for Anorexia Nervosa Dr Meg Spriggs is a researcher at the Centre for Psychedelic Research at Imperial College London where she works as a trial-coordinator and guide on trials of psilocybin. Her primary role is as one of the lead researchers on the Centre‚Äôs upcoming clinical trial assessing psilocybin-assisted psychotherapy  …